Next Steps Following EMBOLISE Trial and Addressing Unmet Needs for Subdural Hematomas: Jason M. Davies, MD, PhD
The assistant professor of neurosurgery and biomedical informatics at the State University of New York at Buffalo discussed the questions that still remain following the EMBOLISE trial and the use of embolization in the treatment of subacute and subdural hematoma. [WATCH TIME: 5 minutes]
WATCH TIME: 5 minutes
"We have a number of planned secondary analyses looking at imaging aspects, how much of the artery you glue, what portion of the artery you glue, health economic outcomes, and whether it can reduce costs of the system and improve quality of life."
Subdural hematomas (SDH) can be divided into 3 groups based on chronology: acute, subacute, and chronic. A subacute SDH is defined as a hematoma that evolves from an acute SDH within 4 to 21 days of head injury. A chronic SDH, which occurs 21 days after head injury, is one of the most common traumatic conditions in the elderly population and dose not necessarily develop from an acute SDH. Although surgical management is technically straightforward, high recurrence rates and comorbidities against elders make minimally invasive alternatives for treatment attractive.
At the
Following the presentation, Davies, an assistant professor of neurosurgery and biomedical informatics at the State University of New York at Buffalo, sat down with NeurologyLive® to describe the next steps in research and what’s left for EMBOLISE. He spoke about the plan to assess those with larger and smaller hematomas, the secondary analyses still left to complete, and the additional questions that remain. Furthermore, he spoke on the unmet needs for this patient population, the challenges that come with treating elders, and managing complications associated with traditionally used surgical procedures.
REFERENCE
1. Knopman J, Davies JM, Harbaugh RE, et al. The EMBOLISE study: embolization of the middle meningeal artery with Onyx Liquid Embolic System in the treatment of subacute and chronic subdural hematoma. Presented at: International Stroke Conference; February 7-9, 2024; Phoenix, AZ. LB28
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.